Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.05% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CTKB · Mar 31, 2025
Cytek Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-25-023927General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-0.30% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-7.59% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
109.38% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
48.62% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-36.12% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
23.46% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
15.99% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History21 statesSelf-history eligible
Sep 30, 20210/7 normalizedLevel 3Dec 31, 20210/7 normalizedLevel 3Mar 31, 20220/7 normalizedLevel 3Jun 30, 20220/8 normalizedLevel 3Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20235/8 normalizedLevel 3Sep 30, 20237/8 normalizedLevel 3Dec 31, 20237/8 normalizedLevel 3Mar 31, 20247/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 1.76%
- Current
- 2.05%
- Delta
- 0.29%
- Previous
- 12.66%
- Current
- -0.30%
- Delta
- -12.96%
- Previous
- 3.85%
- Current
- -7.59%
- Delta
- -11.44%
- Previous
- 21.90%
- Current
- 109.38%
- Delta
- 87.49%
- Previous
- 55.43%
- Current
- 48.62%
- Delta
- -6.81%
- Previous
- -10.24%
- Current
- -36.12%
- Delta
- -25.88%
- Previous
- 19.66%
- Current
- 23.46%
- Delta
- 3.80%
- Previous
- 13.39%
- Current
- 15.99%
- Delta
- 2.60%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CTKB Fundamental State →Transitioned To · CTKB Fundamental State →Transitioned To · CTKB CAPEX_INTENSITY_INCREASED →Transitioned To · CTKB CASH_GENERATION_DECREASED →Transitioned To · CTKB GROWTH_DECREASED →Transitioned To · CTKB INVENTORY_PRESSURE_INCREASED →Transitioned To · CTKB MARGIN_DECREASED →Transitioned To · CTKB PROFITABILITY_DECREASED →Transitioned To · CTKB R_AND_D_INTENSITY_INCREASED →Transitioned To · CTKB SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.